{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T19:41:08Z","timestamp":1649014868899},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T00:00:00Z","timestamp":1210291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s00105-008-1564-5","type":"journal-article","created":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T17:20:33Z","timestamp":1210180833000},"page":"492-498","source":"Crossref","is-referenced-by-count":2,"title":["Supportive Therapie des Melanoms"],"prefix":"10.1007","volume":"59","author":[{"given":"P.","family":"Mohr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,9]]},"reference":[{"key":"1564_CR1","unstructured":"Berger AM et al. (2001) Principles and practice of oncology. Cancer. Lippincott, Philadelphia, pp\u00a02869\u20132880"},{"key":"1564_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1634\/theoncologist.4-3-191","volume":"4","author":"Hesketh","year":"1999","unstructured":"Hesketh PJ (1999) Defining the emetogenicity of cancer chemotherapy regimes: relevance to clinical practice. Oncologist 4: 191\u2013196","journal-title":"Oncologist"},{"key":"1564_CR3","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","volume":"100","author":"Grundberg","year":"2004","unstructured":"Grundberg S et al. (2004) Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer 100: 2261\u20132268","journal-title":"Cancer"},{"key":"1564_CR4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0885-3924(01)00317-7","volume":"22","author":"Hichok","year":"2001","unstructured":"Hichok JT, Roscoe JA, Morrow GR (2001) The role of patients\u2018 expectations in the development of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manage 22(4): 843\u2013850","journal-title":"J Pain Symptom Manage"},{"key":"1564_CR5","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1200\/JCO.2006.06.9591","volume":"24","author":"Kris","year":"2006","unstructured":"Kris M, Hesketh P, Somerfiel M et al. (2006) American Society of Clinical Oncology guideline for antiemetics in oncology. J Clin Oncol 24: 2932\u20132947","journal-title":"J Clin Oncol"},{"key":"1564_CR6","unstructured":"National Comprehensive Cancer Network (2007) Antiemesis. NCCN Clinical Practice Guidelines in Oncology (available at http:\/\/www.cnnc.org)"},{"key":"1564_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/annonc\/mdj078","volume":"17","author":"Roila","year":"2006","unstructured":"Roila R, Hesketh PJ, Herrstedt J et al. (2006) Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17: 20\u201328","journal-title":"Ann Oncol"},{"key":"1564_CR8","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.ejca.2004.07.015","volume":"40","author":"Bokemeyer","year":"2004","unstructured":"Bokemeyer C, Aapro MS, Courdi A et al. (2004) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 40(15): 2201\u20132216","journal-title":"Eur J Cancer"},{"key":"1564_CR9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1200\/JCO.2007.14.3396","volume":"26","author":"Rizzo","year":"2008","unstructured":"Rizzo JD, Somerfiel MR, Hagerty KI et al. (2008) Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology\/American Society of Hematology Clinical Practice Guideline Update. J Clin Oncol 26: 132\u2013149","journal-title":"J Clin Oncol"},{"key":"1564_CR10","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","volume":"42","author":"Aapro","year":"2006","unstructured":"Aapro MS, Cameron DA, Pettengell R et al. (2006) EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patientes with lymphomas and solid tumours. Eur J Cancer 42: 2433\u20132453","journal-title":"Eur J Cancer"},{"key":"1564_CR11","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","volume":"24","author":"Smith","year":"2006","unstructured":"Smith TJ, Khatcheressian J, Lyman GH et al. (2006) Update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24(19): 3187\u20133205","journal-title":"J Clin Oncol"},{"key":"1564_CR12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.1999.17.1.253","volume":"17","author":"Loge","year":"1999","unstructured":"Loge JH, Abrahamsen AF, Ekeberg O et al. (1999) Hodgkin\u2019s disease survivors have more fatigue than the general population. J Clin Oncol 17: 253\u2013261","journal-title":"J Clin Oncol"},{"key":"1564_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s005200050142","volume":"6","author":"Visser","year":"1998","unstructured":"Visser MR, Smets EM (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6: 101\u2013108","journal-title":"Support Care Cancer"},{"key":"1564_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjmed.2005.07.047","volume":"119","author":"Blockmans","year":"2006","unstructured":"Blockmans DM, Persoons P, Van Houdenhove B et al. (2006) Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med 119(2): 167.e23\u201330","journal-title":"Am J Med"},{"key":"1564_CR15","doi-asserted-by":"crossref","unstructured":"Mader I, F\u00fcrst-Weger P, Nogler-Semenitz E et al. (2002) Paravasation von Zytostatika, Springer, Wien","DOI":"10.1007\/978-3-7091-3799-4"},{"key":"1564_CR16","doi-asserted-by":"crossref","unstructured":"Schmoll HJ, H\u00f6ffken K, Possinger K et al. (2006) Kompendium Internistische Onkologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo","DOI":"10.1007\/3-540-31303-6"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-008-1564-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1564-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T10:23:38Z","timestamp":1588674218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-008-1564-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,9]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["1564"],"URL":"https:\/\/doi.org\/10.1007\/s00105-008-1564-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,9]]}}}